APAC, LATAM, MENA, CIS: Unlock Accelerated Regulatory Pathways, Break Into New Markets and Maintain Global Compliance
Keep Up With The Fast-Evolving Market Access Requirements With Direct Guidance From Government Bodies and Pharmaceutical Regulatory Leaders
Including Harmonisation Efforts, China's Drug Administration Law, The Impact of COVID-19 And Much More
Obtain updates from government bodies and industry to get one step closer to breaking into:
APAC
APAC
- Delve into China’s Drug Administration Law with Menarini Ricerche
- Hear experiences with Market Authorisation in China with Chiesi Group
- Get updates into ASEAN with Merck, GSK, GS1 Global and more!
LATAM
LATAM
- Updates straight from authorities: ANVISA, Cofepris, and Cuban Regulatory Authority (CECMED)
- Immerse yourself in case studies on orphan drug registration, APIs and Market Access
- Assess how COVID has impacted LATAM regulation with input from CIRS
MENA
MENA
- Get to grips with MENA’s regulatory landscape with industry experts
- Join interactive sessions on product registration in the GCC with Astrazenca and Acino
- Discuss risk Management with - Head of Iraqi Pharmacovigilance Centre, Ministry of Health Iraq
EAEU & CIS
EAEU & CIS
- Keep informed about the latest updates on the Eurasian Economic Union (EAEU)
- Learn best practices for product registration from real-life scenarios
- Understand the latest labelling requirements in EAEU and CIS markets
It's time to overcome your global regulatory hurdles
Connect with pioneers in the pharmaceutical regulatory landscape to help you:
